Annals of Emergency Medicine
Volume 46, Issue 2 , Pages 198-200 , August 2005

Are We Putting the Cart Ahead of the Horse: Who Determines the Standard of Care for the Management of Patients in the Emergency Department?

  • Francis M. Fesmire, MD
    • ,
  • Andy Jagoda, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Andy Jagoda, MD, Mount Sinai School of Medicine, Emergency Department, 1 Gustave Levy Place, Box 1149, New York, NY 10029-6500; 212-241-2987, fax 212-426-1946

References 

  1. Gibler WB, Cannon CP, Blomkalns AL, et al. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department. Ann Emerg Med. 2005;46:185–197
  2. Centre for Evidence Based Medicine. Available at: http://www.cebm.net/levels_of_evidence.asp.
  3. Eddy DM. Designing a practice policy: standards, guidelines, and options. JAMA. 1990;26:3077–3084
  4. Oosterhuis WP, Brun DE, Watinej J, et al. Evidence based guidelines in laboratory medicine: principles and methods. Clin Chem. 2004;50:806–818
  5. American College of Emergency Physicians . Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann Emerg Med. 2000;35:521–544
  6. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  7. Yusif S, Shamir RM, Zhao F, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003;107:966–972
  8. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  9. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411–2420
  10. PURSUIT Trial Investigators . Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436–443
  11. Bhatt DL, Marso SP, Houghtaling P, et al. Does earlier administration of eptifibatide reduce death and MI in patients with acute coronary syndromes?. Circulation. 1998;98(suppl 1):I560–I561
  12. Bazzino O, Aylward P, Hains A, et al. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina: Platelet Receptor Inhibition in Ischemic Syndromes Management (PRISM) Study Investigators. N Engl J Med. 1998;338:1498–1505

 Supervising editor: Michael L. Callaham, MDFunding and support: The authors report this study did not receive any outside funding or support.Reprints not available from the authors.

PII: S0196-0644(05)00718-3

doi: 10.1016/j.annemergmed.2005.05.027

Annals of Emergency Medicine
Volume 46, Issue 2 , Pages 198-200 , August 2005

Article Tools